TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact Read More
GSK's Viiv Healthcare gets FDA approval for new dose of HIV treatment Read More
PRESS: Activist investor Cevian builds stake in Vodafone - Bloomberg Read More
LONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight Read More
LONDON BROKER RATINGS: Fresnillo and Polymetal hit by downgrades Read More
Unilever undergoes "spring clean" amid investor pressure Read More
TOP NEWS: Under pressure Unilever to cut 1,500 jobs amid restructure Read More
LONDON MARKET MIDDAY: Stocks sink on fears of Ukraine conflict Read More
PRESS: Activist hedge fund Trian builds stake in Unilever - FT Read More
LONDON MARKET CLOSE: FTSE 100 down as BP, Shell and AB Foods weigh Read More
Unilever shares turn lower despite backing away from GSK consumer bid Read More
LONDON MARKET MIDDAY: FTSE 100 stalls as AB Foods drags on index Read More
LONDON MARKET OPEN: Glaxo down as Unilever refuses to up consumer bid Read More
Unilever failed bid for GSK unit reveals pain of sustainability shift Read More
TOP NEWS: Unilever decides against sweetening GSK consumer arm bid Read More
GlaxoSmithKline promotes internally as chief scientist set for US move Read More
LONDON MARKET CLOSE: Stocks rise as China cuts rates on policy loans Read More
LONDON MARKET MIDDAY: GSK rises, Unilever falls on consumer health bid Read More
TOP NEWS SUMMARY: GSK rebuffs Unilever; Credit Suisse ousts chair Read More
LONDON MARKET OPEN: Glaxo buoyed by Unilever's consumer arm approach Read More
